Product ID:846 5080,CONCENTRATE,KODAK CINEFLURE H.S. DEVELOPER
MSDS Date:12/06/2000
FSC:NIIN:Submitter:D DG
Status Code:A
MSDS Number: CLGYS

EASTMAN KODAK COMPANY

343 STATE STREET
ROCHESTER, NY 14650
US

Emergency Phone: 716-722-5151

Info Phone: 716-722-5151

Cage: 19139

EASTMAN KODAK CO US CUSTOMER SERVICE/GOVERNMENT SALES

ROCHESTER, NY 14650-3129 US

Telephone: 800-828-6203

Cage: 5K871

WATER

CAS: 7732-18-5

RTECS: ZC0110000

POTASSIUM SULFITE

CAS: 10117-38-1

RTECS: WT3530000

HYDROQUINONE (SARA 302/313) (CERCLA)

CAS: 123-31-9

RTECS: MX3500000

OSHA PEL 2 MG/M3

ACGIH TLV: 2 MG/M3; 9596

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

DIETHYLENE GLYCOL

CAS: 111-46-6

RTECS: ID5950000

SODIUM SULFITE

CAS: 7757-83-7

RTECS: WE2150000

4-(HYDROXYMETHYL)-4-METHYL-1-PHENYL-3-PYRAZOLIDONE

CAS: 13047-13-7

Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION: EXPECTED TO BE LOW HAZARD
FOR USUAL INDUSTRIAL OR COMMERCIAL HANDLING BY TRAINED PERSONNEL.
IN CONTACT WITH STRONG ACIDS OR IF HEATED, SULFITES MAY LIBERATE
SULFUR DIOXIDE GAS. SULFUR DIO XIDE GAS IS IRRITATING TO
RESPIRATORY TRACT. SOME ASTHMATICS OR HYPERSENSITIVE INDIVIDUALS
MAY EXPERIENCE DIFFICULT BREATHING. EYES: CAUSES IRRITATION. SKIN:
CAUSE ALLERGIC SKIN REACTION BASED ON HUMA N EXPERIENCE. MAY CAUSE
SKIN DEPIGMENTATION. PROLONGED OR REPEATED CONTACT WITH AQUEOUS
SOLUTIONS MAY CAUSE IRRITATION. INGESTION: HARMFUL IF SWALLOWED.
Explanation of Carcinogenicity:CARCINOGENICITY CLASSIFICATION
(COMPONENTS PRESENT AT 0.1% OR MORE): - INTERNATIONAL AGENCY FOR
RESEARCH ON CANCER (IARC): NONE - AMERICAN CONFERENCE OF
GOVERNMENTAL INDUSTRIAL HYGIENISTS (ACGIH): NON E - NATIONAL
TOXICOLOGY PROGRAM (NTP): NONE - OCCUPATIONAL SAFETY AND HEALTH
ADMINISTRATION (OSHA): NONE
Effects of Overexposure:INHALATION: EXPECTED TO BE LOW HAZARD FOR USUAL
INDUSTRIAL OR COMMERCIAL HANDLING BY TRAINED PERSONNEL. IN CONTACT
WITH STRONG ACIDS OR IF HEATED, SULFITES LIBERATE SULFUR DIOXIDE
GAS. SULFUR DIOXIDE GAS IS IRRITATING TO RESPIRATORY TRACT. SOME
ASTHMATICS OR HYPERSENSITIVE INDIVIDUALS MAY EXPERIENCE DIFFICULT
BREATHING. EYES: CAUSES IRRITATION. SKIN: CAUSE ALLERGIC SKIN
REACTION BASED ON HUMAN EX PERIENCE. MAY CAUSE SKIN DEPIGMENTATION.
PROLONGED OR REPEATED CONTACT WITH AQUEOUS SOLUTIONS MAY CAUSE
IRRITATION. INGESTION: HARMFUL IF SWALLOWED.
Medical Cond Aggravated by Exposure:SOME ASTHMATICS OR
SULFITE-SENSITIVE INDIVIDUALS MAY EXPERIENCE WHEEZING, CHEST
TIGHTNESS, STOMACH UPSET, HIVES, FAINTNESS, WEAKNESS AND DIARRHEA.

First Aid:INHALATION: IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT
SYMPTOMATICALLY. GET MEDICAL ATTENTION IF SYMPTOMS PERSIST. EYES:
IMMEDIATELY FLUSH WITH WATER AT LEAST 15 MINUTES. GET MEDICAL
ATTENTION IF SYMPTO MS OCCUR. SKIN: IMMEDIATELY FLUSH WITH WATER AT
LEAST 15 MINUTES, REMOVING CONTAMINATED CLOTHING AND SHOES. IF SKIN
IRRITATION OR ALLERGIC SKIN REACTION, GET MEDICAL ATTENTION. WASH
CONTAMINATED CLOTH ING BEFORE REUSE. DESTROY OR THOROUGHLY CLEAN
CONTAMINATED SHOES. INGESTION: ONLY INDUCE VOMITING AT INSTRUCTION
OF MEDICAL PERSONNEL. CALL PHYSICIAN OR POISON CONTROL CENTER
IMMEDIATELY. NEVER GIVE A NYTHING BY MOUTH TO UNCONSCIOUS PERSON.

Flash Point:NONFLAMMABLE
Extinguishing Media:WATER SPRAY, CARBON DIOXIDE (CO2), DRY CHEMICAL,
ALCOHOL FOAM
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING. FIRE OR EXCESSIVE HEAT MAY PRODUCE HAZARDOUS
DECOMPOSITION PRODUCTS.
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNTS OF WATER.
OTHERWISE, ABSORB SPILL WITH VERMICULITE OR OTHER INERT MATERIAL,
THEN PLACE IN A CONTAINER FOR CHEMICAL WASTE. CLEAN SURFACE
THOROUGHLY TO REMOVE RESIDUAL CONTAMINATION.
Neutralizing Agent:NONE

Handling and Storage Precautions:KEEP CONTAINER CLOSED. KEEP AWAY FROM
INCOMPATIBLE SUBSTANCES (SEE INCOMPATIBILITY SECTION).KEEP FROM
CONTACT WITH OXIDIZING MATERIALS.
Other Precautions:AVOID PROLONGED OR REPEATED BREATHING OF MIST OR
VAPOR. AVOID CONTACT WITH EYES, SKIN, AND CLOTHING. USE WITH
ADEQUATE VENTILATION. WASH THOROUGHLY AFTER HANDLING.

Respiratory Protection:NONE SHOULD BE NEEDED.
Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES PER
HOUR) SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO
CONDITIONS.
Protective Gloves:WEAR IMPERVIOUS GLOVES AND PROTECTIVE CLOTHING
APPROPRIATE FOR RISK OF EXPOSURE
Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES).
Other Protective Equipment:EYE BATH, WASHING FACILITIES, SAFETY SHOWER
Work Hygienic Practices:NOT PROVIDED
Supplemental Safety and Health

HCC:B3
Boiling Pt:B.P. Text:NOT AVAILABLE
Vapor Pres:NOT AVAILABLE
Vapor Density:0.6
Spec Gravity:1.25
pH:10.3
Solubility in Water:COMPLETE
Appearance and Odor:LIGHT YELLOW LIQUID, NO ODOR
Percent Volatiles by Volume:66 WT

Stability Indicator/Materials to Avoid:YES
STRONG ACIDS.
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:SULFUR DIOXIDE

Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT
TO NATIONAL, STATE, OR LOCAL LAWS. FLUSH TO SEWER WITH LARGE
AMOUNTS OF WATER. SINCE EMPTIED CONTAINERS RETAIN PRODUCT RESIDUE,
FOLLOW LABEL WARNINGS E VEN AFTER CONTAINER IS EMPTIED.

Toxicological Information:CONTAINS HYDROQUINONE. IN F-344 RATS CHRONIC
ORAL ADMINISTRATION OF HYDROQUINONE RESULTED IN FORMATION OF BENIGN
KIDNEY TUMORS THOUGHT TO BE SECONDARY TO NEPHROPATHY. HYDROQUINONE
INDUCED NEPHROPATHY FOLLOWING ORAL ADMINISTRATION HAS BEEN NOTED
IN MALE F-344 RAT, BUT NOT IN OTHER SPECIES OF RAT STRAINS TESTED.
ALTHOUGH AN INCREASE IN MONONUCLEAR CELL LUKEMIA IN F-344 FEMALE
RATS HAS BEEN REPORTED FOLLOWING CHRONIC ORAL ADMINISTRATION OF
HYDROQUINONE, THIS FINDING NOT REPRODUCED IN SUBSEQUENT STUDY. NO
EVIDENCE OF CARCINOGENICITY IN MALE MICE FOLLOWING CHRONIC ORAL
ADMINISTRATION OF HYDROQUINON E. (SEE OTHER INFORMATION FIELD)

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:EFFECTS OF HYDROQUINONE: FISH LC50: 1-10 MG/L, DAPHNID EC50:
<1 MG/L, ALGAL IC50: 10-100 MG/L, ORGANICS READILY DEGRADABLE
(>70%): YES (14 DAYS), POTENTIAL BIOACCUMULATION LOW POW <1, COD:
240 G/L, BO D5: 117 G/L, POTENTIAL TOXICITY WASTE TREATMENT
MICROORGANISMS EC50: >100 MG/L.

Transport Information:NOT REGULATED PER KODAK TRANSPORTATION HOTLINE.

SARA Title III Information:HYDROQUINONE IS A 313 CHEMICAL. THE EHS RQ
IS 100 LB
Federal Regulatory Information:NOT PROVIDED
State Regulatory Information:CONTAINS NO CHEMICALS KNOWN TO THE STATE
OF CALIFORNIA TO CAUSE CANCER OR REPRODUCTIVE HARM.